Immunotherapy with γδ T-cells: the future is there

被引：1
|
作者：
Kabelitz, Dieter [1 ,2 ]
Yin, Zhinan [3 ,4 ,5 ]
机构：
[1] Univ Kiel, Inst Immunol, Campus Kiel, D-24105 Kiel, Germany
[2] Univ Hosp Schleswig Holstein, Campus Kiel, D-24105 Kiel, Germany
[3] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Inst Translat Med, Guangdong Prov Key Lab Tumor Intervent Diag & Trea, Zhuhai 519000, Peoples R China
[4] Jinan Univ, Sch Med, State Key Lab Bioact Mol & Druggabil Assessment, Guangzhou 510632, Peoples R China
[5] Jinan Univ, Minist Educ, Key Lab Viral Pathogenesis Infect Prevent & Contro, Guangzhou 510632, Peoples R China
来源：
IMMUNOTHERAPY | 2024年 / 16卷 / 11期
关键词：
adoptive cell therapy; bispecific T-cell engager; chimeric antigen receptor; delta one T-cells; immunotherapy; phosphoantigen; vitamin C; gamma delta T-cells;
D O I：
10.1080/1750743X.2024.2365622
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：705 / 708
页数：4
相关论文
共 50 条
  • [21] Immunotherapy of Intrahepatic Cholangiocarcinoma with Fc Chimeric Receptor T-Cells
    Kurokawa, Tomohiro
    Kontos, Filippos
    Yamada, Teppei
    Wang, Xinhui
    Ferrone, Soldano
    Ferrone, Cristina R.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S264 - S264
  • [22] CAR T-cells: current limitations and future developments
    Alcantara, Marion
    Houot, Roch
    HEMATOLOGIE, 2020, 26 : 38 - 45
  • [23] Chimeric Antigen Receptor T-Cells: The Future Is Now
    Mchayleh, Wassim
    Bedi, Prabhjot
    Sehgal, Rajesh
    Solh, Melhem
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02):
  • [24] Development of CAR T-cells for future treatment of NETs
    Mandriani, B.
    Pelle, E.
    Mannavola, F.
    Ingravallo, G.
    Cazzato, G.
    Ramello, M. C.
    Porta, C. G.
    Strosberg, J. R.
    Abate-Daga, D.
    Cives, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S911 - S911
  • [25] Adoptive cellular immunotherapy of cancer in mice using allogeneic T-cells
    Bartels, CJ
    Rosenberg, SA
    Yang, JC
    ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (01) : 67 - 73
  • [26] IMMUNOTHERAPY WITH CAR T-CELLS IN THE TREATEMENT OF RECURRENT GLIOBLASTOMAS: A SYSTEMATIC REVIEW
    Souza, P. H. L.
    Fracaroli, N. O.
    Almeida, I. M.
    Suaid, R. G.
    Guaresqui, H. A.
    Motta, R. N. T.
    Monici, V. C.
    Moyses, R. C. A.
    Moraes, G. A.
    Ramalho, A. O.
    Berriel, C. C.
    Bellotti, G. K.
    Nogueira, B., V
    NEURO-ONCOLOGY, 2024, 26 : V68 - V69
  • [27] Immunotherapy of malignant pleural mesothelioma using MET specific T-cells
    Thayaparan, T.
    Van der Stegen, S.
    Pereira, A. Parente
    Petrovic, R.
    Spicer, J.
    Maher, J.
    LUNG CANCER, 2014, 83 : S28 - S28
  • [28] SPECIFICITY OF THE T-CELLS THAT MEDIATE AND SUPPRESS ADOPTIVE IMMUNOTHERAPY OF ESTABLISHED TUMORS
    DYE, ES
    NORTH, RJ
    JOURNAL OF LEUKOCYTE BIOLOGY, 1984, 36 (01) : 27 - 37
  • [29] Tumor-Associated Antigen Presentation by γδ T-Cells in Cancer Immunotherapy
    Kramer, Anne Marijn
    Yan, Mengyong
    Peggs, Karl S.
    Anderson, John
    Gustafsson, Kenth
    BLOOD, 2014, 124 (21)
  • [30] Identification of human tumor antigens recognized by T-cells and their use for immunotherapy
    Kawakami, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (05) : 427 - 434
12345